Summit Trail Advisors, LLC Vertex Pharmaceuticals Inc Transaction History

Summit Trail Advisors, LLC

$2.68 Billion
Q4 2024

A detailed history of Summit Trail Advisors, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Summit Trail Advisors, LLC holds 4,409 shares of VRTX stock, worth $2.14 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

4,409

Previous 3,264 35.08%

Holding current value

$2.14 Million

Previous $1.52 Million 16.93%

% of portfolio

0.07%

Previous 0.04%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 29, 2025	BUY	$396.64 - $516.74 $454,152 - $591,667	1,145 Added 35.08%	4,409 $1.78 Million
Q3 2024 Nov 12, 2024	BUY	$460.0 - $505.78 $176,180 - $193,713	383 Added 13.29%	3,264 $1.52 Million
Q2 2024 Aug 13, 2024	BUY	$392.81 - $485.53 $146,125 - $180,617	372 Added 14.83%	2,881 $1.35 Million
Q1 2024 Apr 23, 2024	BUY	$407.69 - $446.08 $167,152 - $182,892	410 Added 19.53%	2,509 $1.05 Million
Q4 2023 Feb 06, 2024	SELL	$343.0 - $410.68 $89,180 - $106,776	-260 Reduced 11.02%	2,099 $854,000
Q3 2023 Oct 30, 2023	BUY	$338.18 - $362.46 $234,020 - $250,822	692 Added 41.51%	2,359 $820,000
Q2 2023 Jul 25, 2023	BUY	$314.42 - $351.91 $296,812 - $332,203	944 Added 130.57%	1,667 $586,000
Q1 2023 May 04, 2023	BUY	$283.23 - $323.1 $204,775 - $233,601	723 New	723 $227,000
Q1 2019 May 16, 2019	SELL	$163.73 - $194.7 $228,567 - $271,801	-1,396 Closed	0 $0
Q4 2018 Feb 13, 2019	SELL	$151.91 - $192.21 $257,487 - $325,795	-1,695 Reduced 54.84%	1,396 $231,000
Q3 2018 Nov 14, 2018	BUY	$167.73 - $192.74 $45,958 - $52,810	274 Added 9.73%	3,091 $596,000
Q2 2018 Aug 10, 2018	SELL	$145.72 - $169.96 $948,928 - $1.11 Million	-6,512 Reduced 69.8%	2,817 $479,000
Q1 2018 May 22, 2018	SELL	$151.6 - $177.13 $144 Million - $168 Million	-946,738 Reduced 99.02%	9,329 $956,000
Q1 2018 May 21, 2018	BUY	$151.6 - $177.13 $144 Million - $168 Million	947,878 Added 11575.02%	956,067 $956,000
Q4 2017 Feb 14, 2018	BUY	$137.28 - $155.55 $1.12 Million - $1.27 Million	8,189	8,189 $1.34 Million

Others Institutions Holding VRTX

# of Institutions

1,757

Shares Held

228M

Call Options Held

1.63M

Put Options Held

1.47M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $125B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Summit Trail Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Summit Trail Advisors, LLC with notifications on news.

Account

Summit Trail Advisors, LLC Vertex Pharmaceuticals Inc Transaction History